2023Q1营收下滑10%,营业利润和净利润继续小幅亏损,目前缺乏吸引力。查看全文
$Psychemedics(PMD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001171843-20-002951 Act: 34 Size: 25 KB 网页链接
$Psychemedics(PMD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001171843-20-002949 Act: 34 Size: 29 KB 网页链接
$Psychemedics(PMD)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-10-24 AccNo: 0001171843-19-006773 Size: 16 MB 网页链接
$Psychemedics(PMD)$ 8-K - Current report Filed: 2019-10-22 AccNo: 0001171843-19-006697 Size: 108 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Psychemedics(PMD)$ 8-K - Current report Filed: 2019-09-19 AccNo: 0001171843-19-006022 Size: 20 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Psychemedics(PMD)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-13 AccNo: 0001171843-19-005455 Size: 132 KB 网页链接
$Psychemedics(PMD)$ 美东时间 2019-08-05 分红: 0.18 网页链接
$Psychemedics(PMD)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-07-24 AccNo: 0001171843-19-004764 Size: 2 MB 网页链接
$Psychemedics(PMD)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001171843-19-004725 Size: 94 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Psychemedics(PMD)$ 内部交易: 2019-06-05,副总裁 Sales & Mktg,Doucot Charles M ,买入,500普通股, $9.90